CRNA Circio Holding ASA

0.9650USD9.330 NOK · OSL+2.64%Mkt Cap: 280.78M USDP/E: —

Circio Holding ASA, a biotechnology company, develops novel circular RNA expression technology for gene and cell therapy. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three cli…

Key Statistics

Company
Market Cap280.78M USD
Enterprise Value209.26M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-4.75M USD
Revenue/Share—
Last Price0.9650 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees10
CountryNO
SectorHealthcare
IndustryBiotechnology
ISINNO0013033795
Valuation
P/E (Trailing)—
P/E (Forward)-30.10
PEG—
EV/EBITDA-32.11
EV/Revenue—
P/S—
P/B4.94
EPS (TTM)-0.04 USD
EPS (Forward)-0.03 USD
52W Range
0.094157% of range1.624
52W High1.624 USD
52W Low0.0941 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE367.49%
ROA-426.80%
ROIC—
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.74M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-0.92%
Net Debt-55.75M USD
Net Debt/EBITDA8.55
Net Debt/FCF—
Balance Sheet
Debt/Equity-0.67
Current Ratio20.42
Quick Ratio20.42
Book Value/Sh0.20 USD
Cash/Share0.20 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateOct 4, 2023
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.290.97M
Float222.08M
Insiders30.07%
Institutions7.32%
Technical
SMA 501.110 (-13.1%)
SMA 2000.8858 (+8.9%)
Beta-1.33
S&P 52W Chg12.00%
Avg Vol (30d)2.56M
Avg Vol (10d)2.85M
Technical Indicators
RSI (14)38.1
MACD-0.4369
MACD Signal-0.3923
MACD Hist.-0.0445
BB Upper1.173 USD
BB Middle1.030 USD
BB Lower0.8868 USD
BB Width27.79%
ATR (14)0.0479 USD
Vol Ratio (20d)0.43x

About Circio Holding (OSL: CRNA)

›

Circio Holding (OSL: CRNA) is listed on Oslo Børs, where its shares trade in NOK. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 10 employees.

The shares were at 9.330 NOK on 19 November 2026, up 910.8% over 52 weeks. Its 52-week range is 0.9100 NOK to 15.70 NOK: the price is 40.6% below the high and 925.3% above the low.

Its market capitalisation is 2.71B NOK.

Circio Holding reports return on equity of 367.5% and an operating margin of 0.0%.

It holds more cash than debt, a net cash position of 539.01M NOK. Its Piotroski F-score is 2 out of 9, a weak reading of its financial health. The next earnings report is expected on 14 April 2027.